Patents by Inventor Feiyang LIU

Feiyang LIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250104795
    Abstract: Examples of the present disclosure provide a memory device, a memory system and an operation method of the memory system, and a storage medium. The memory device includes: multiple word lines, where a plurality of strings coupled to each of the word lines are divided into a first string area and a second string area; and at least one redundant stripe corresponding to each of the word lines, where the redundant stripe comprises a first redundant stripe which is configured to store first check data. The first check data is obtainable by performing error correction coding on data in a first string area of a word line where the first redundant stripe is located and data in a second string area of a word line adjacent to the word line where the first redundant stripe is located.
    Type: Application
    Filed: January 10, 2024
    Publication date: March 27, 2025
    Inventors: Feiyang ZHANG, Hongwen LIU
  • Publication number: 20250080013
    Abstract: The invention pertains to a mobile intelligent terminal with emergency charging function. The terminal comprises a smartphone and an emergency power generating assembly cooperating with the smartphone; the emergency power generating assembly includes an induction coil and a first magnet reciprocating relative to the induction coil, the first magnet moves relative to the induction coil to cut the magnetic induction lines of the first magnet, the induction coil is used to charge a lithium battery of the smartphone. By shaking the smartphone, the first magnet moves relative to the induction coil, making the induction coil to cut the magnetic induction lines of the first magnet to generate an electromotive force, achieving energy conversion and transmission. By rotating the driving assembly, it is able to generate power for temporary calls or location service when there is no power bank or external power supply, thus the present invention has strong practicality.
    Type: Application
    Filed: October 12, 2023
    Publication date: March 6, 2025
    Applicant: Dongguan Jinconn New Material Co., Ltd.
    Inventors: Liang CHEN, Song CHEN, Xiangyang LIU, Wei LI, Huaping XU, Feiyang LIU
  • Publication number: 20240406360
    Abstract: The present disclosure provides an image enhancement processing method and apparatus, a device and a storage medium, which relate to the field of artificial intelligence technology, especially to the field of cloud computing technology. The specific implementation scheme is: in response to an input image read, obtaining a color space corresponding to the input image and all color pixels of at least one color component in the color space; determining sharpened pixel values respectively corresponding to pixel positions of all the color pixels; determining smoothed sharpened pixel values respectively corresponding to all the pixel positions based on the sharpened pixel values respectively corresponding to the pixel positions of all the color pixels; obtaining a to-be-coded image corresponding to the input image according to the smoothed sharpened pixel values respectively corresponding to all the pixel positions.
    Type: Application
    Filed: June 18, 2024
    Publication date: December 5, 2024
    Inventor: Feiyang LIU
  • Publication number: 20240319169
    Abstract: The present invention provides a cell culture medium for culturing primary gastrointestinal stromal tumor cells, comprising gastrin, N2, insulin, a receptor tyrosine kinase ligand, and a Rock kinase inhibitor. The present invention further provides a method for culturing gastrointestinal stromal tumor cells by using the cell culture medium, and an application and a method of an expanded cell population, which is obtained by using the method, in efficacy evaluation or screening.
    Type: Application
    Filed: January 22, 2021
    Publication date: September 26, 2024
    Applicant: PRECEDO PHARMACEUTICALS CO., LTD
    Inventors: Qingsong LIU, Feiyang LIU, Xiaoyu LI, Husheng MEI, Wenchao WANG, Tao REN, Li WANG
  • Patent number: 11752544
    Abstract: A centrifugal casting apparatus comprising an upper portion into which molten material is poured, the upper portion having a central rotational axis about which the apparatus is rotated; at least one block runner is connected to the upper portion at the proximal end of the block runner and to at least one mould at the distal end of the block runner, the block runner being mounted substantially perpendicular to the axis of rotation; and wherein the moulds are oriented substantially parallel to the axis of rotation of the centrifugal casting apparatus.
    Type: Grant
    Filed: November 4, 2021
    Date of Patent: September 12, 2023
    Assignee: ROLLS-ROYCE plc
    Inventors: Rui Yang, Yuyou Cui, Paul A Withey, Nicholas Green, Feiyang Liu
  • Publication number: 20220389379
    Abstract: Provided is a culture medium containing amphiregulin for culturing primary breast epithelial cells and a culture method involving using the medium. In the culturing method, primary cells are cultured on a culture vessel coated with an extracellular matrix gel by using the culture medium, and the primary cells grow on the culture vessel, which has been coated with the extracellular matrix gel, and proliferate rapidly under the combined action of nutrient factors and an extracellular matrix contained in the primary cell culture medium. The cell model obtained by the primary cell culture medium and the primary cell culture method can be used for the evaluating the efficacy of and screening drugs.
    Type: Application
    Filed: November 18, 2019
    Publication date: December 8, 2022
    Applicant: PRECEDO PHARMACEUTICALS CO., LTD
    Inventors: Qingsong LIU, Feiyang LIU, Husheng MEI, Wenchao WANG, Ming ZHAO, Zongru JIANG, Tao REN, Li WANG
  • Publication number: 20220143685
    Abstract: A centrifugal casting apparatus comprising an upper portion into which molten material is poured, the upper portion having a central rotational axis about which the apparatus is rotated; at least one block runner is connected to the upper portion at the proximal end of the block runner and to at least one mould at the distal end of the block runner, the block runner being mounted substantially perpendicular to the axis of rotation; and wherein the moulds are oriented substantially parallel to the axis of rotation of the centrifugal casting apparatus.
    Type: Application
    Filed: November 4, 2021
    Publication date: May 12, 2022
    Applicant: ROLLS-ROYCE PLC
    Inventors: Rui YANG, Yuyou CUI, Paul A WITHEY, Nicholas GREEN, Feiyang LIU
  • Patent number: 10793543
    Abstract: The present invention provides a compound represented by formula (I), or a pharmaceutically acceptable salt, a solvate, an ester, an acid, a metabolite or a prodrug thereof. The compound itself in the present invention or in combination with at least one therapeutic agent can be used for preventing or treating diseases, disorders or symptoms caused by the adjustment of the activity of tyrosine kinase C-KIT, or affected by the activity of the tyrosine kinase C-KIT or involving in the activity of the tyrosine kinase C-KIT, especially cancers or other cell proliferation diseases.
    Type: Grant
    Filed: March 28, 2017
    Date of Patent: October 6, 2020
    Assignees: PRECEDO PHARMACEUTICALS CO., LTD, HEFEI GRACEVO BIO-MEDICINE CO., LTD
    Inventors: Qingsong Liu, Jing Liu, Qiang Wang, Beilei Wang, Feiyang Liu, Shuang Qi, Ziping Qi, Fengming Zou, Cheng Chen, Wenchao Wang, Chen Hu, Xiaochuan Liu, Wei Wang, Aoli Wang, Li Wang, Zhenquan Hu, Tao Ren
  • Publication number: 20190084960
    Abstract: The present invention provides a compound represented by formula (I), or a pharmaceutically acceptable salt, a solvate, an ester, an acid, a metabolite or a prodrug thereof. The compound itself in the present invention or in combination with at least one therapeutic agent can be used for preventing or treating diseases, disorders or symptoms caused by the adjustment of the activity of tyrosine kinase C-KIT, or affected by the activity of the tyrosine kinase C-KIT or involving in the activity of the tyrosine kinase C-KIT, especially cancers or other cell proliferation diseases.
    Type: Application
    Filed: March 28, 2017
    Publication date: March 21, 2019
    Applicants: PRECEDO PHARMACEUTICALS CO., LTD, HEFEI GRACEVO BIO-MEDICINE CO., LTD
    Inventors: Qingsong LIU, Jing LIU, Qiang WANG, Beilei WANG, Feiyang LIU, Shuang QI, Ziping QI, Fengming ZOU, Cheng CHEN, Wenchao WANG, Chen HU, Xiaochuan LIU, Wei WANG, Aoli WANG, Li WANG, Zhenquan HU, Tao REN